150 related articles for article (PubMed ID: 15052701)
1. Combo approved for HIV treatment.
Nurse Pract; 2004 Mar; 29(3):40. PubMed ID: 15052701
[No Abstract] [Full Text] [Related]
2. Boosted saquinavir approved.
AIDS Patient Care STDS; 2004 Mar; 18(3):183. PubMed ID: 15112642
[No Abstract] [Full Text] [Related]
3. FDA notifications. Potential serious effect of combination saquinavir-ritonavir.
AIDS Alert; 2010 Apr; 25(4):45-6. PubMed ID: 20564774
[No Abstract] [Full Text] [Related]
4. Searching for the right dose of ritonavir-saquinavir.
TreatmentUpdate; 2001 Sep; 13(5):3. PubMed ID: 11768860
[No Abstract] [Full Text] [Related]
5. [Ritonavir/Saqinavir: dual protease inhibitor combination. Salvage therapy].
MMW Fortschr Med; 2000; 142(3 Suppl):41. PubMed ID: 11012293
[No Abstract] [Full Text] [Related]
6. Combination suppresses HIV RNA within the central nervous system.
AIDS Patient Care STDS; 1998 Jan; 12(1):65. PubMed ID: 11361893
[No Abstract] [Full Text] [Related]
7. Combination study of Invirase and Norvir starting.
AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361633
[No Abstract] [Full Text] [Related]
8. The use of saquinavir/ritonavir 1000/100 mg twice daily in patients with tuberculosis receiving rifampin.
Losso MH; Lourtau LD; Toibaro JJ; Saenz C; González C
Antivir Ther; 2004 Dec; 9(6):1031-3. PubMed ID: 15651762
[No Abstract] [Full Text] [Related]
9. Saquinavir once daily.
TreatmentUpdate; 2002; 14(4):4. PubMed ID: 12064314
[No Abstract] [Full Text] [Related]
10. Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg.
Ananworanich J; Siangphoe U; Mahanontharit A; Hill A; Hirschel B; Ruxrungtham K
Antivir Ther; 2004 Dec; 9(6):1035-6. PubMed ID: 15651763
[No Abstract] [Full Text] [Related]
11. From grapefruit juice to ritonavir.
TreatmentUpdate; 2001; 12(12):5-6. PubMed ID: 11570093
[No Abstract] [Full Text] [Related]
12. Lower dose of ritonavir approved for use with fosamprenavir.
Sax PE
AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
[No Abstract] [Full Text] [Related]
13. FDA approves new dosing for amprenavir and ritonavir combination.
AIDS Treat News; 2002 Mar; (378):6-7. PubMed ID: 11965920
[No Abstract] [Full Text] [Related]
14. New formulation of saquinavir (Fortovase) is more effective.
Tam CW
Fac Notes (New Orleans La); 1998; 10(2):11. PubMed ID: 11365126
[TBL] [Abstract][Full Text] [Related]
15. Norvir capsule approved.
AIDS Patient Care STDS; 1999 Sep; 13(9):567. PubMed ID: 10813038
[No Abstract] [Full Text] [Related]
16. The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy.
Staszewski S; Babacan E; Stephan C; Haberl A; Carlebach A; Gute P; Klauke S; Hermschulte Y; Stuermer M; Dauer B;
J Antimicrob Chemother; 2006 Nov; 58(5):1024-30. PubMed ID: 16956902
[TBL] [Abstract][Full Text] [Related]
17. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
Schouten JT
STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
[TBL] [Abstract][Full Text] [Related]
18. [New formulation--fewer tablets--optimal effect].
Krankenpfl J; 2005; 43(7-10):249. PubMed ID: 16515318
[No Abstract] [Full Text] [Related]
19. Pill burden reduced for saquinavir.
AIDS Patient Care STDS; 2005 Feb; 19(2):128. PubMed ID: 15747430
[No Abstract] [Full Text] [Related]
20. About the NDA filing.
AIDS Patient Care STDS; 1997 Dec; 11(6):455. PubMed ID: 11361869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
